Cargando…

Efficacy and Safety of CalliSpheres(®) Drug-Eluting Beads Transarterial Chemoembolization in Barcelona Clinic Liver Cancer Stage C Patients

This study aimed to investigate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) treatment in Barcelona Clinic Liver Cancer (BCLC) stage C liver cancer patients. In 39 patients with BCLC stage C liver cancer, after the first cycle of DEB-TACE, 2 (5.1%) and 24...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yaohong, Huang, Wensou, He, Mingji, Lian, Hui, Guo, Yongjian, Huang, Jingjun, Zhou, Jingwen, Zhu, Kangshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848450/ https://www.ncbi.nlm.nih.gov/pubmed/30005719 http://dx.doi.org/10.3727/096504018X15313896322888

Ejemplares similares

Drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres for treatment of unresectable intrahepatic cholangiocarcinoma
por: Zhou, Tan-Yang, et al.
Publicado: (2020)

Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres(®) in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres(®) Transarterial Chemoembolization in Liver Cancer (CTILC) Study
por: Sun, Junhui, et al.
Publicado: (2020)

Clinical outcomes of doxorubicin-eluting CalliSpheres beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma
por: Bi, Yonghua, et al.
Publicado: (2021)

Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads
por: Bi, Yonghua, et al.
Publicado: (2022)

Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
por: Zhou, Guan-Hui, et al.
Publicado: (2018)

Initial experience of drug-eluting bead transarterial chemoembolization with CalliSpheres(®) microspheres in treating liver metastases patients
por: Zhang, Guangqiang, et al.
Publicado: (2020)

Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma
por: Kong, Jian, et al.
Publicado: (2020)

Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients
por: Zhao, Guangsheng, et al.
Publicado: (2021)

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
por: Huang, Jingjun, et al.
Publicado: (2021)

CalliSpheres drug-eluting beads transarterial-chemoembolization in the treatment of liver metastases from breast cancer: Initial experience in 14 patients
por: Chang, Xu, et al.
Publicado: (2021)

Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer
por: Zhang, Jiao, et al.
Publicado: (2021)

Comparison of CalliSpheres(®) Microspheres Drug-eluting Beads and Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Shi, Zhongxing, et al.
Publicado: (2023)

Efficacy and safety of transarterial chemoembolization with CalliSpheres® Microspheres in head and neck cancer
por: Gao, Fei, et al.
Publicado: (2022)

CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study
por: Wu, Baolin, et al.
Publicado: (2018)

Efficacy and safety of CalliSpheres(®) drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC study
por: Wu, Xia, et al.
Publicado: (2019)

An investigation of efficacy, safety, and prognostic factors of drug‐eluting beads‐transarterial chemoembolization operation with CalliSpheres(®) Microspheres in treating Chinese hepatocellular carcinoma patients
por: Zhang, Xin, et al.
Publicado: (2019)

Safety and efficacy of drug-eluting bead transarterial chemoembolization with CalliSpheres® microsphere for hepatocellular carcinoma with portal vein tumor thrombus: a preliminary study
por: Zhou, Tan-Yang, et al.
Publicado: (2021)

Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study
por: Luo, Jun, et al.
Publicado: (2020)

The Comprehensive Analysis of Efficacy and Safety of CalliSpheres(®) Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort Study
por: Peng, Zhiyi, et al.
Publicado: (2020)

Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers
por: Zhang, Shuisheng, et al.
Publicado: (2017)

A comparative study of efficacy and safety of transarterial chemoembolization with CalliSpheres and conventional transarterial chemoembolization in treating unresectable intrahepatic cholangiocarcinoma patients
por: Sun, Tao, et al.
Publicado: (2022)

Optimized Loading of Idarubicin in CalliSpheres(®) Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties
por: Lu, Enhao, et al.
Publicado: (2021)

Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres(®) Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
por: Liang, Bin, et al.
Publicado: (2021)

Chemoembolization with CalliSpheres drug-eluting beads loaded with irinotecan in the treatment of unresectable colorectal cancer liver metastases: preliminary results in 16 cases
por: Kong, Jian, et al.
Publicado: (2019)

Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis
por: Li, Haitao, et al.
Publicado: (2023)

Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
por: Bi, Yonghua, et al.
Publicado: (2022)

Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres(®) Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
por: Duan, Xuhua, et al.
Publicado: (2022)

CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma
por: Xiang, Hua, et al.
Publicado: (2019)

Early changes in peripheral blood cytokine levels after the treatment of metastatic hepatic carcinoma with CalliSpheres microspheres drug-eluting beads transcatheter arterial chemoembolization
por: Liu, Ying, et al.
Publicado: (2022)

Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis
por: Bi, Yonghua, et al.
Publicado: (2022)

Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
por: Huang, Jingjun, et al.
Publicado: (2022)

Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Huang, Jingjun, et al.
Publicado: (2021)

Correction to: Zhang etal., Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers
Publicado: (2017)

CalliSpheres(®) microsphere transarterial chemoembolization combined with (125)I brachytherapy for patients with non–small‐cell lung cancer liver metastases
por: Zhao, Guangsheng, et al.
Publicado: (2022)

Comparison of chemoembolization with CalliSpheres(®) microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study
por: Liang, Bin, et al.
Publicado: (2020)

Tirapazamine-loaded CalliSpheres microspheres: Preparation and characterization as a chemoembolization agent for liver cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Hepatic Arterial Chemoembolization With Arsenic Trioxide Eluting CalliSpheres Microspheres Versus Lipiodol Emulsion: Pharmacokinetics And Intratumoral Concentration In A Rabbit Liver Tumor Model
por: Duan, Xu-hua, et al.
Publicado: (2019)

Efficacy and safety of CalliSpheres drug-eluting beads for bronchial arterial chemoembolization for refractory non-small-cell lung cancer and its impact on quality of life: A multicenter prospective study
por: Zhao, Yu Wei, et al.
Publicado: (2023)

Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma
por: Liu, Haitao, et al.
Publicado: (2023)

Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients
por: Peng, Ning, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8vjcou5gj82jougcbk0r7bcpb